Dr. Fauci

Dr. Fauci
ask people worried
People ask me, 'How worried should we be?
prepare scenario
Not to prepare for the worst-case scenario would be completely irresponsible.
among bird certainly chances chickens containing developed developing eliminate good identify nations prevent rapidly sick spread
It isn't an absolute, but you certainly can say that the chances of containing spread among bird flocks in developed nations that have good agricultural capabilities and controls, to identify rapidly and cull and eliminate the sick chickens to prevent spread . . . is much better than in some other developing nations.
occurred unclear whether
It is unclear whether the mutation occurred in the person or whether it occurred in the chicken.
developing great mean vaccine
Developing a vaccine doesn't mean we will stockpile it to a great extent.
doubt
Every day there's another country. It's going to go all the way across, there's no doubt about it.
anybody chickens compensate countries critical europe incentive infected issue sell united western
It won't be what you see in countries in which there is no regulation, in which there is no incentive to compensate farmers, in which the people, who are so poor, when they see their chickens are getting infected they immediately sell them or they don't tell anybody because they don't want them culled. That is a critical issue that is fundamentally different than what we see in Western Europe and that we will see in the United States.
aiming capacity develop doses latest months six ultimately vaccine version within
We're aiming at 20-million doses of a pre-pandemic vaccine but to develop the capacity to be able to make 300-million doses within six months of when we ultimately get the latest version of it that is the real killer.
earlier failed healthy hoped immunity increases next percent rate response shot shown step studies third
With seasonal flu, the response rate in healthy young adults ranges from 60 to 90 percent. We all hoped for 70 percent with this vaccine, but it wasn't to be. The next step is to give a booster to those who failed to respond, which we're already doing. Earlier studies have shown a third shot often increases immunity dramatically.